The oral cavity and gastric involvement in mycosis fungoides while on systemic bexarotene therapy: A rare case report.

Bayramgürler, Dilek; Kazan, Didem; Eruyar, Tugrul; Demirkesen, Cüyan; Demirbas, Abdullah

Bayramgürler, Dilek; Kazan, Didem; Eruyar, Tugrul; Demirkesen, Cüyan; Demirbas, Abdullah.

Bayramgürler D; Department of Dermatology, Faculty of Medicine, Kocaeli University, Kocaeli, Turkey.
Kazan D; Department of Dermatology, Faculty of Medicine, Kocaeli University, Kocaeli, Turkey.
Eruyar T; Department of Pathology, Faculty of Medicine, Kocaeli University, Kocaeli, Turkey.
Demirkesen C; Department of Pathology, Faculty of Medicine, Acibadem University, Istanbul, Turkey.
Demirbas A; Department of Dermatology, Faculty of Medicine, Kocaeli University, Kocaeli, Turkey.

Dermatol Ther ; 35(4): e15349, 2022 04.

Article in English | MEDLINE | ID: covidwho-1794708

Subject(s)

Anticarcinogenic Agents; Mycosis Fungoides; Skin Neoplasms; Anticarcinogenic Agents/adverse effects; Bexarotene/therapeutic use; Humans; Mouth; Mycosis Fungoides/drug therapy; Skin Neoplasms/drug therapy; Tetrahydronaphthalenes/adverse effects

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Skin Neoplasms / Mycosis Fungoides / Anticarcinogenic Agents Type of study: Case report Limits: Humans Language: English Journal: Dermatol Ther Journal subject: Dermatology Year: 2022 Document Type: Article Affiliation country: Dth.15349

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google